PCO371
a parathyroid hormone type 1 receptor (PTHR1) agonist for the treatment of hypoparathyroidism
Also Known As:
1-(3,5-dimethyl-4-(2-((4-oxo-2-(4-(trifluoromethoxy)phenyl)-1,3,8-triazaspiro(4.5)dec-1-en-8-yl) sulfonyl)ethyl)phenyl)-5,5-dimethylimidazolidine-2,4-dione
Networked: 1
relevant articles (1 outcomes,
0 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
| 1. | Arai, Shinichi:
1 article
(11/2016)
|
| 2. | Esaki, Tohru:
1 article
(11/2016)
|
| 3. | Hoshino, Maiko:
1 article
(11/2016)
|
| 4. | Joyashiki, Eri:
1 article
(11/2016)
|
| 5. | Kawabe, Yoshiki:
1 article
(11/2016)
|
| 6. | Kinosaki, Masahiko:
1 article
(11/2016)
|
| 7. | Kitamura, Hidetomo:
1 article
(11/2016)
|
| 8. | Miyake, Taiji:
1 article
(11/2016)
|
| 9. | Nishimura, Yoshikazu:
1 article
(11/2016)
|
| 10. | Noda, Hiroshi:
1 article
(11/2016)
|